Life Insurance
Consensus Index

AI Consensus Fit Review

Protective Life Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders Fit Review

Protective Life is a qualified but time-sensitive fit for indexed universal life insurance with chronic-illness or long-term-care riders.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Protective Life is a qualified but time-sensitive fit for indexed universal life insurance with chronic-illness or long-term-care riders. Four of seven platforms named Protective Life during the ranking stage (57.1% of included platform responses), with an average listed rank of 5.5 and a best rank of 1. The strongest reason to consider it is the combination of Protective Indexed Choice UL with the optional ExtendCare chronic-illness rider, which can accelerate part of the death benefit for qualifying chronic illness. The main limitation is availability: multiple platforms report Indexed Choice UL closed to new sales on March 9, 2026, and no confirmed successor IUL with ExtendCare was identified.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms (anthropic, grok, kimi, openai)
Share of included platform responses57.1%
Average listed rank5.5
Best listed rank1 (openai)
Relevant product/model/planProtective Indexed Choice UL paired with the optional ExtendCare chronic-illness rider
Overall use-case fitMixed to good, with a material availability caveat
Research date2026-09-20

Why Protective Life Qualified for This Study

Questions This Section Answers

  • Is Protective Life a good choice for Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders?
  • Why did Protective Life qualify for this IUL with chronic illness rider study if its main product was discontinued?

Protective Life qualified because it matched both halves of the buyer's requirement: a named indexed universal life product and a named chronic-illness living-benefit rider. Protective publicly markets Protective Indexed Choice UL as an indexed universal life insurance product [1], and the company has publicly described the ExtendCare chronic-illness rider for life insurance [2]. The relevant combination across platforms is Indexed Choice UL paired with the optional ExtendCare rider [3].

Four of seven platforms named Protective Life during ranking discovery, at an average listed rank of 5.5 and a best rank of 1 (openai). The remaining three platforms evaluated fit but did not name the entity in the ranking stage, so their fit ratings are recorded without a rank contribution.

Qualification is not the same as current availability. Multiple platforms report that Indexed Choice UL stopped accepting new applications on March 9, 2026, with policies required to be in force by June 5, 2026 [5]. That closure is the single most important fact in this review, and it is why the fit rating is split across platforms rather than unanimous.

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders

Questions This Section Answers

  • Which Protective Life product should a buyer choose for indexed universal life with a chronic illness rider?
  • Does Protective Indexed Choice UL with ExtendCare still exist for new buyers in 2026?

The relevant product is Protective Indexed Choice UL with the optional ExtendCare chronic-illness rider. Protective materials identify Indexed Choice UL as a flexible-premium universal life policy issued by Protective Life Insurance Company [9]. The cited product form is UL-27, with a New York variation, UL-27-NY [11].

ExtendCare is an optional accelerated death benefit rider that advances part of the policy death benefit when the insured is certified as chronically ill [13]. Protective describes direct monthly payments, no requirement to submit bills or receipts, use of benefits for medical or non-medical expenses, and preservation of unused death benefit for beneficiaries [16].

Availability is the central problem. Protective's own transition notice states Indexed Choice UL closed effective March 9, 2026, with signed applications and Part II interviews due by that date and all policies in force by June 5, 2026 [12]. An independent product-change tracker reports the same discontinuation and notes a fixed-account crediting rate increase to 3.50% alongside the closure [20]. A third independent source lists the same March 9, 2026 deadline and a February 21, 2026 last day to submit electronic ticket business [23].

No platform located a publicly confirmed successor IUL product carrying ExtendCare. One platform reports that sources suggest Protective may have transitioned buyers to Advantage Choice UL or Lifetime Assurance UL, but no definitive documentation of a recommended successor with ExtendCare was located (anthropic). That is a platform-reported inference, not a confirmed product fact, and buyers should treat it as unverified.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Protective Life Indexed Choice UL with ExtendCare?
  • Is ExtendCare a long-term-care policy or a chronic illness rider?

Platforms broadly agreed on four points.

First, the product-rider pairing is correct for this use case. Every platform that named Protective Life identified Indexed Choice UL with ExtendCare as the relevant combination (openai, anthropic, grok, kimi, perplexity, google, deepseek).

Second, ExtendCare is a chronic-illness accelerated death benefit, not standalone long-term-care insurance. Protective's older rider disclosure describes the rider as supplemental to traditional long-term-care policies [24]. The NAIC buyer's guide describes chronic-illness riders generally as life-insurance living benefits that accelerate death benefit rather than paying a separate LTC benefit [25]. One platform notes that chronic-illness accelerations reduce death benefit and cash value, and that not all riders provide true LTC insurance or state LTC law protections [26].

Third, the rider is available only at policy issue. Multiple platforms report ExtendCare cannot be added later and cannot be reinstated once terminated [27].

Fourth, financial strength is high. Protective reports, as of June 30, 2026, insurer financial-strength ratings for Protective Life Insurance Company of A+ from A.M. Best, AA- from S&P Global Ratings, AA- from Fitch and Aa3 from Moody's [31]. A.M. Best separately affirmed an A+ (Superior) financial strength rating and aa- long-term issuer credit rating with a stable outlook [33]. Ratings are opinions, can change and are not purchase recommendations.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Is Protective Life still a good fit for IUL with chronic illness riders after the Indexed Choice UL discontinuation?
  • How much does the Protective ExtendCare rider cost, and why is pricing unclear?

Fit ratings diverged. Three platforms rated Protective a good fit (openai, perplexity, google), two rated it mixed (deepseek, grok), and two rated it uncertain (anthropic, kimi). The split tracks one variable: how heavily each platform weighted the March 2026 product closure.

The openai assessment treats the product as a credible candidate and emphasizes rider mechanics, benefit limits and policy charges (openai). The anthropic assessment leads with discontinuation and states that prospective buyers must first verify whether Protective still offers IUL with living-benefit riders (anthropic). The kimi assessment states that publicly available ExtendCare detail is sparse and that competitors offer more transparent LTC rider structures (kimi).

Benefit figures conflict. Protective marketing materials cite a $12,600 monthly maximum tied to the 2025 IRS per-diem limit of $420 per day [36]. One platform reports a 2026 update to $12,900 monthly with possible state variation (grok). Another reports a historical range from roughly $9,900 in older producer guides to $12,600 under current limits (google). The actual amount depends on policy death benefit, rider terms, IRS limits, state rules and the issued contract (openai).

Pricing is not publicly standardized. No platform located a verified public retail price list for the policy or the rider (openai, deepseek, perplexity, kimi). One platform reports a marketing illustration showing $28,404 annual premium for a specific 55-year-old male, standard-risk, $2 million death-benefit example, and explicitly states that example is not a quote or typical price (openai). Another reports average monthly premiums of approximately $325 for men and $280 for women on $500,000 of coverage (anthropic). A third reports average monthly costs of $54.61 for women and $70.83 for men without specifying face amount or product [39]. These figures are not reconcilable from the supplied evidence and should not be treated as comparable.

Charge disclosures also conflict by vintage. One cited producer guide reports an 8% premium load, a $9 monthly administrative charge and a $25 withdrawal fee [40]. Independent review data reports a 12% premium load in policy years 1–9 dropping to 5% in year 10 [41]. One platform reports a guaranteed 12% premium load, a $9 monthly administrative charge, a $25 withdrawal fee and guaranteed 8% loan interest (grok). The producer guide cited by openai is dated 2023 and may not reflect every 2026 state variation or current product version (openai).

Customer-experience data is inconsistent. One independent review reports a J.D. Power score of 597, ranked 20th of 22 providers [43]. The same review source is described elsewhere as reporting 597 at 21st place, and earlier data as 20th out of 22 (anthropic). The exact ranking varies by source vintage.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What chronic illness benefit triggers and payout limits does Protective ExtendCare use?
  • Does Protective ExtendCare require receipts or restrict how benefits are spent?

ExtendCare pays on chronic-illness certification. Protective states that chronic illness generally requires inability to perform at least two of six Activities of Daily Living for 90 days, or severe cognitive impairment requiring supervision [44]. Certification must come from a licensed health care practitioner, and one rider guide states certification within the last 12 months [47].

The payout model is indemnity-style. Payments go directly to the policy owner, and no bills, receipts or monthly proof of care expenses are required [48]. One platform describes this as the rider's core practical advantage because it allows payment for informal or family-provided care (google).

Benefit limits are capped. Company materials state monthly benefits are capped at up to 5% of the base policy death benefit, with a minimum monthly benefit of $250 [51]. The per-diem limit reached $420 per day, or up to $12,600 monthly, for policies issued with a 2025 effective date [52]. One platform reports a 2026 update to $12,900 monthly (grok).

Premium waiver is a documented feature. One platform reports that with the third consecutive annual chronic illness certification, representing 25 consecutive months on claim, all policy premiums and policy expenses are permanently waived, and that no premium payments are required while on claim [54]. Another platform reports premiums and expenses waived during claim after three years of chronic illness (grok).

The indexed account carries a 0% floor. Protective materials describe index crediting with a 0% floor, which limits negative index-crediting for that account but does not eliminate policy charges, deductions, loan effects or lapse risk [49]. One product guide cites a 3% cap rate and 100% participation rate in the S&P 500, with a fixed account guaranteed rate of 1% [56]. Another source reports the fixed account crediting rate increased to 3.50% at the time of product closure [57].

Index strategy breadth is a documented limitation. Independent analysis notes Protective offered fewer index strategy options than competitors, citing Ethos with nine index options including S&P 500, Russell 2000, NASDAQ-100 and volatility-controlled strategies [58].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Protective Indexed Choice UL with ExtendCare cost per month, and what fees apply?
  • What surrender, loan and lapse terms apply to Protective Indexed Choice UL?

No verified public premium schedule exists for Indexed Choice UL or ExtendCare. Premiums depend on age, sex, underwriting class, face amount, rider selection, state and policy design (openai, deepseek). Pricing confidence is rated low by four platforms (openai, deepseek, perplexity, kimi) and moderate by two (anthropic, google).

Reported cost elements, with their conflicts preserved:

Cost elementReported figureSource platform
Premium load8% (2023 producer guide)
Premium load12% years 1–9, 5% year 10+,
Premium loadGuaranteed 12%grok
Monthly administrative charge$9, grok
Withdrawal fee$25, grok
Loan interestGuaranteed 8%grok
Loan interestNon-guaranteed, last disclosed ~5.29%anthropic
Fixed account guaranteed rate1%
Fixed account crediting rate at closure3.50%
Minimum death benefit$100,000, grok
ExtendCare rider chargeNot publicly disclosedopenai, anthropic, deepseek, perplexity, kimi

The ExtendCare rider is available at additional cost and generally must be selected at policy issue [60]. Month-to-date rider cost deductions reduce the policy's cost basis [62]. No platform published the rider's premium or monthly cost, which prevents price comparison against competing living-benefit riders (anthropic, kimi).

Contract terms to note. Lapse protection is conditional and may be shortened or lost after loans, withdrawals, premium changes or insufficient funding [63]. One platform reports no rider termination is allowed during the minimum lapse protection period [64]. Death benefit protection is reported as guaranteed to age 90, with premiums and charges discontinuing at age 121 [65]. Standard two-year contestability and suicide periods apply (anthropic, google). Surrender charges apply during the surrender-charge period (openai, kimi).

State availability is restricted. The cited producer guide states ExtendCare is not available in California or New York [63]. One platform notes ExtendCare was not available in California pre-2026 updates (grok). Another notes that in New York, Protective Indexed Choice NY UL (form UL-27-NY) was issued with the same features, while also stating ExtendCare availability varies by state [66]. These statements are not fully consistent and should be verified state by state.

Best Suited For

Questions This Section Answers

  • Who is Protective Life Indexed Choice UL with ExtendCare best suited for?
  • Is Protective Life worth it for a buyer who wants chronic illness benefits without submitting receipts?

Protective is best suited to buyers who already hold an in-force Indexed Choice UL policy with an ExtendCare rider, or who applied before the March 9, 2026 closure. For that group, the product combines permanent death-benefit coverage, indexed cash-value potential with a 0% floor, and a chronic-illness rider that pays without receipts [69].

It also suits buyers who specifically want indemnity-style chronic-illness access rather than reimbursement-based long-term-care coverage. One platform rates this as the rider's defining advantage because benefits can pay informal caregivers, family members or home modifications (google).

It suits applicants who can sustain illustrated premiums and policy charges and who value a financially strong issuer. Protective reports A+ from A.M. Best, AA- from S&P Global Ratings, AA- from Fitch and Aa3 from Moody's as of June 30, 2026 [71].

It suits buyers who want premium waiver during extended illness. One platform documents permanent waiver of premiums and policy expenses after three consecutive annual chronic illness certifications [73].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Protective Life for indexed universal life with a chronic illness rider?
  • Is Protective Life a bad choice for a buyer who needs comprehensive long-term-care insurance?

Buyers seeking new coverage as of September 2026 are the clearest mismatch. Multiple platforms report Indexed Choice UL closed to new applications on March 9, 2026, and no confirmed successor IUL with ExtendCare was identified [74].

Buyers who need comprehensive long-term-care insurance are also a mismatch. ExtendCare is a chronic-illness accelerated death benefit, and Protective's older rider disclosure describes it as supplemental to traditional long-term-care policies [78]. The NAIC describes chronic-illness riders generally as living benefits that accelerate death benefit rather than standalone LTC coverage [79].

Buyers in states where ExtendCare is unavailable are a mismatch. The cited producer guide states it is not available in California or New York [80].

Buyers who need guaranteed cash-value performance are a mismatch. Illustrated cap rates and cash-value outcomes are not guaranteed and may change, and indexed-account floors do not prevent policy-level charges, declining cash value, loan effects or lapse (openai).

Buyers who want maximum index strategy flexibility are a mismatch. Independent analysis notes Protective offered fewer index options than competitors such as Ethos [82].

Buyers who want online quote-and-apply are a mismatch. Protective IUL policies required agent consultation, and medical exams were required for most applicants [84].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Protective Life for a buyer who needs true long-term-care coverage?
  • Which alternative beats Protective Life for a buyer who wants more index strategy options?

A dedicated long-term-care policy may be better when the buyer wants a benefit pool designed primarily for extended-care expenses rather than acceleration of life insurance (openai). One platform notes that dedicated LTC policies may offer reimbursement benefits or broader care-specific design (perplexity).

A guaranteed universal-life policy may be better when predictable death-benefit guarantees matter more than indexed cash-value potential (openai).

A competing IUL carrier may be better on index strategy breadth. One platform cites Ethos with nine index options including S&P 500, Russell 2000, NASDAQ-100 and volatility-controlled strategies [85]. Another platform cites John Hancock LifeCare with 2, 4 or 6 year benefit periods and an optional 5% compound inflation rider, and Mutual of Omaha with a chronic illness rider at no additional charge using an actuarial discount at claim plus an LTC rider with fixed monthly cost, reimbursement and up to $1M benefit for ages 30–79 [87]. These competitor details are platform-reported from company producer materials and were not independently verified.

A different carrier may be better if it offers the desired rider in the buyer's state with lower rider charges, stronger contractual benefit guarantees or more favorable chronic-illness definitions (openai).

A traditional IUL without a rider may be better when the buyer does not need living benefits and wants to avoid rider costs (openai).

A term-to-permanent conversion path may be better if the buyer prioritizes lower initial premiums over current permanent coverage (perplexity).

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Protective Life before signing an Indexed Choice UL contract?
  • How does ExtendCare affect Medicaid eligibility and death benefit for beneficiaries?

Verify these items directly with Protective or a licensed producer before signing:

  1. Is Protective offering a successor IUL product to the discontinued Indexed Choice UL, and does it include the ExtendCare chronic illness rider? (anthropic)
  2. Is ExtendCare available in the buyer's state and on the exact policy form being offered? (openai, perplexity)
  3. What is the rider charge, how is it calculated, and can it change? (openai, anthropic)
  4. What percentage or dollar amount of the death benefit can be accelerated, and how are remaining death benefits and cash value calculated after acceleration? (openai)
  5. Does the 90-day qualification or waiting period apply separately to each claim, and what documentation is required? [89]
  6. Are benefits reimbursed, indemnity-based or paid without receipts under the current state-specific rider? [90]
  7. What are the guaranteed and current cap rates, participation rates, spreads, fixed-account rates and illustrated assumptions? (openai)
  8. What premium is required to keep the policy in force and maintain lapse protection under guaranteed and non-guaranteed scenarios? (openai)
  9. What are the surrender charges, loan rates, withdrawal fees, premium loads and cost-of-insurance charges in the issued contract? (openai)
  10. How do loans, withdrawals and accelerated benefits affect taxes, cash value, death benefit, lapse risk and beneficiary proceeds? (openai)
  11. How does IRC Section 101(g) classification affect qualification for Medicaid, Supplemental Security Income or other state public assistance programs in the buyer's jurisdiction? (anthropic, google)
  12. Which legal insurer issues the policy, and what are its current state-specific financial-strength ratings and complaint information? (openai)
  13. Does the rider require ongoing annual recertification for benefit continuation on the specific form offered? (perplexity)
  14. Are in-force Indexed Choice UL policies with ExtendCare riders protected from future rate increases or rider termination? (anthropic)

Final AI Consensus Verdict

Protective Life is a qualified but availability-constrained fit for indexed universal life insurance with chronic-illness or long-term-care riders. Four of seven platforms named it during ranking, at an average listed rank of 5.5 and a best rank of 1. Fit ratings split three good, two mixed and two uncertain, and the split tracks how heavily each platform weighted the March 9, 2026 closure of Indexed Choice UL.

The strongest case for Protective is the product-rider combination itself: permanent indexed universal life with a 0% indexed-account floor, plus an indemnity-style chronic-illness rider that pays without receipts, waives premiums during extended claim and preserves unused death benefit for beneficiaries [91]. The strongest case against is that the flagship product is closed to new sales and no confirmed successor with ExtendCare was located [94].

Buyers with in-force policies retain a solid, competitively structured permanent product backed by high reported financial-strength ratings [98]. Prospective buyers must first confirm whether Protective currently offers IUL with a living-benefit rider, then compare against dedicated long-term-care coverage and competing IULs. ExtendCare is not comprehensive LTC insurance, pricing is individualized, public product materials are not fully current or state-specific, and policy-level charges and lapse risk can materially affect outcomes (openai).

This review covers one carrier within a broader field. The full Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders comparison set includes competing carriers evaluated against the same criteria.

Buyers who want to review adjacent permanent-coverage categories can browse the wider life insurance directory.

How This Review Was Produced

This review was produced from seven AI platform responses to a single buyer-scenario prompt about indexed universal life insurance with chronic-illness, long-term-care or similar living-benefit riders. The research date is 2026-09-20. Platform-reported research dates range from 2026-06-04 (deepseek) to 2026-09-21 (all other platforms); these are provenance metadata and do not independently prove freshness.

Platform mentions in the ranking stage count only platforms that named Protective Life during ranking discovery. All seven platforms evaluated fit, but only four named the entity in ranking. Fit ratings were recorded per platform as supplied.

Citations are platform-reported evidence, not independently verified facts. Company-owned citations materially outnumber independent citations in the supplied catalog, so company claims are not described here as independently verified. No platform performed hands-on product testing, and no customer experience was measured directly.

Methodology Limitations

  • Platform-reported research dates differ from the authoritative run date of 2026-09-20. One platform's research is dated 2026-06-04, roughly three months earlier than the rest.
  • One platform (deepseek) ran with search disabled, so its findings are model-reported rather than retrieval-backed.
  • Official-site retrieval failed for at least one platform during ranking, so identity details and product-rider mapping should be verified directly with Protective.
  • The supplied URLs were collected from platform responses and were not independently validated.
  • Company-owned sources outnumber independent sources in the catalog, which limits independent corroboration of product mechanics and pricing.
  • No verified public, standardized retail price list was found for Indexed Choice UL or the ExtendCare rider.
  • The most detailed cited producer guide is dated 2023 and may not reflect every 2026 state variation or current product version.
  • Benefit maximums conflict across sources ($9,900 historical, $12,600 for 2025 effective dates, $12,900 reported for 2026), and the actual amount depends on policy, rider, IRS and state limits.
  • Premium load disclosures conflict (8% versus 12% years 1–9 versus guaranteed 12%) and cannot be reconciled from the supplied evidence.
  • Customer-experience rankings conflict (20th versus 21st of 22) across source vintages.
  • No confirmed successor IUL product with ExtendCare was located; one platform's suggestion of Advantage Choice UL or Lifetime Assurance UL is platform-reported and unverified.
  • Platform agreement on a carrier does not establish product quality, suitability for any individual buyer, or future performance.

Sources

Company-Owned Sources

Independent Sources

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
50
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#5

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

18 independent · 32 company-owned

Evidence support

44 direct · 4 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

364e078a93f9477a87585ddb4864a1bcc00f37478a7d53b69b5a365e46393288